MARY VITALE: Open Payments
NPI 1760823546 · WOODLAND PARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$549 in 33 payments from 16 companies in 2025. Trend: 2023 $723 · 2024 $748 · 2025 $549
Food & beverage: $549
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $97 |
| Novo Nordisk Inc | 3 | $52 |
| Exact Sciences Corporation | 3 | $52 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $51 |
| GlaxoSmithKline, LLC. | 3 | $50 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $47 |
| Bausch Health US, LLC | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Dexcom, Inc. | 1 | $21 |
| Abbott Laboratories | 1 | $20 |
Products named: Cologuard Collection Kit, XIFAXAN, TRELEGY ELLIPTA, UBRELVY, APLENZIN, JARDIANCE, QULIPTA, AIRSUPRA.
Industry payments across NJ — which companies pay providers there.
